Orbit Discovery Raises $7.6M in Funding
Orbit Discovery Raises $7.6M in Funding Orbit Discovery, an Oxford, England, UK-based biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, raised $7.6m (USD) in funding. The financing was led by Oxford Sciences Innovation, with participation from Borealis Ventures, Perivoli Innovations, and other institutional and individual investors, including Kapil Dev Joory. Proceeds from the financing will be used to accelerate the company’s growth. Led by Dr. Neil Butt, Chief Executive Officer, O...
Source: finsmes.com